Follow-Up Results Of A Phase 2 Study Assessing The Safety And Efficacy Of Mitapivat Treatment, An Oral Pyruvate Kinase Activator, For Up To 60 Weeks In Subjects With Sickle Cell Disease
Mitapivat
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Follow-Up Results Of A Phase 2 Study Assessing The Safety And Efficacy Of Mitapivat Treatment, An Oral Pyruvate Kinase Activator, For Up To 60 Weeks In Subjects With Sickle Cell Disease ### Output: Mitapivat